Trials / Terminated
TerminatedNCT01640886
Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA
Prospective Study Into the Performance of the KeyPathtm MRSA/MSSA Blood Culture Test - BTA
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 764 (actual)
- Sponsor
- MicroPhage, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In vitro identification of S. aureus,methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA)from positive blood culture using MicroPhage's bacteriophage-based diagnostic platform.
Detailed description
This is a multi-center clinical study to investigate the effectiveness of the performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA. The KeyPath test is performed directly on positive blood culture specimens from bioMerieux BacT/ALERT blood culture bottles. The MicroPhage test will be compared to standards and market available tests with similar indications (comparators). It is estimated that the study will last 3-4 months depending on the accural rate at the institutions.
Conditions
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2012-07-16
- Last updated
- 2013-01-15
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01640886. Inclusion in this directory is not an endorsement.